The Alkaline Phosphatase (ALP) test is a common blood test that measures the amount of an enzyme called alkaline phosphatase in your bloodstream. ALP is found in many tissues, but the highest amounts are typically in the liver, bile ducts (the tubes that carry bile from the liver to the intestine), and bones. Because of this, ALP is often used as an enzyme test to help assess liver health, bile duct function, and bone health.

In plain language, your ALP level helps your clinician understand whether there may be irritation, blockage, or disease in the liver/bile ducts, or increased activity in bone (such as growth, healing, or certain bone disorders). Higher-than-normal ALP can suggest problems like bile duct obstruction, inflammation of the bile ducts, liver disease, or increased bone turnover. Lower-than-normal ALP is less common but can be linked to issues such as poor nutrition, certain vitamin/mineral deficiencies, or rare bone conditions.

ALP results are interpreted in context. Levels can normally vary by age (children and teens often have higher ALP due to bone growth) and may change during pregnancy. Your provider will often review ALP alongside other tests such as AST, ALT, GGT, bilirubin, calcium, phosphate, and vitamin D to better pinpoint whether the source is more likely liver/bile duct related or bone related.

A clinician may order an ALP test as part of a routine comprehensive metabolic panel or targeted evaluation when symptoms or risk factors suggest a liver, bile duct, or bone problem. It is also commonly used to monitor known conditions over time and to check how well treatment is working.

ALP testing is often recommended if you have symptoms that may point to liver disease or bile duct issues, such as:

• Yellowing of the skin or eyes (jaundice)
• Dark urine or pale/clay-colored stools
• Itching (especially with jaundice)
• Pain or fullness in the upper right abdomen
• Nausea, poor appetite, unexplained weight loss, or fatigue

It may also be ordered when symptoms suggest a bone disorder or abnormal bone metabolism, including:

• Persistent or unexplained bone or joint pain
• Bone deformity, suspected Paget disease, or abnormal imaging results
• Frequent fractures or concern for metabolic bone disease
• Follow-up of bone healing after a fracture (in some situations)

Other reasons your provider might order an ALP diagnostic test include monitoring medication effects (some medicines can affect the liver), evaluating abnormal liver enzymes found on screening labs, or investigating potential gallbladder/bile duct blockage (for example, from gallstones). When ALP is elevated, a related test called GGT (gamma-glutamyl transferase) may be checked to help determine whether the elevation is more likely coming from the liver/bile ducts rather than bone.

• Bile duct obstruction (cholestasis), including gallstones or bile duct strictures
• Hepatitis (viral, autoimmune, or drug-induced liver inflammation)
• Fatty liver disease (MASLD/NAFLD and MASH/NASH)
• Cirrhosis and chronic liver disease
• Primary biliary cholangitis (PBC)
• Primary sclerosing cholangitis (PSC)
• Cholangitis (infection/inflammation of the bile ducts)
• Bone disorders with increased bone turnover (e.g., Paget disease of bone)
• Osteomalacia (often related to vitamin D deficiency) and other metabolic bone conditions
• Hyperparathyroidism (can affect bone metabolism and ALP)
• Bone metastases or certain bone tumors (may raise ALP)
• Hypophosphatasia (rare condition associated with low ALP)

• Supporting and monitoring liver health as part of preventive care or routine blood work
• Evaluating bile duct and gallbladder function when symptoms suggest bile flow blockage
• Tracking metabolic health and overall wellness alongside other liver enzymes and metabolic markers
• Monitoring treatment response in known liver or bile duct conditions (e.g., cholestatic liver diseases)
• Assessing bone health in suspected metabolic bone problems (often with calcium, phosphate, and vitamin D)
• Helping investigate unexplained bone pain, fractures, or abnormal imaging findings
• Medication safety monitoring when drugs may affect liver enzymes